Literature DB >> 12608880

Treatment of infectious diarrhea in children.

Nure H Alam1, Hasan Ashraf.   

Abstract

Diarrheal diseases remain an important cause of childhood morbidity and death in developing countries, although diarrheal deaths have significantly declined in recent years, mostly due to successes in the implementation of oral rehydration therapy (ORT), which is the principal treatment modality. Diarrhea may occur for varied reasons; however, most episodes of diarrhea in developing countries are infectious in origin. Three clinical forms of diarrhea (acute watery diarrhea, invasive diarrhea, and persistent diarrhea) have been identified to formulate a management plan. Acute diarrhea may be watery (where features of dehydration are prominent) or dysenteric (where stools contain blood and mucus). Rehydration therapy is the key to management of acute watery diarrhea, whereas antimicrobial agents play a vital role in the management of acute invasive diarrhea, particularly shigellosis and amebiasis. In persistent diarrhea, nutritional therapy, including dietary manipulations, is a very important aspect in its management, in addition to rehydration therapy. Rehydration may be carried out either by the oral or intravenous route, depending upon the degree of dehydration. Oral rehydration salts (ORS) solution (World Health Organization formula) is recommended for ORT. Intravenous fluid is recommended for initial management of severe dehydration due to diarrhea, followed by ORT with ORS solution for correction of ongoing fluid losses. Antimicrobial therapy is beneficial for cholera and shigellosis. Antiparasitic agents are indicated only if amebiasis and giardiasis are present. Appropriate feeding during diarrhea is recommended for nutritional recovery and to prevent bodyweight loss. Antidiarrheal agents do not provide additional benefit in the management of infectious diarrhea. Although some probiotics have been shown to be beneficial in the treatment of acute diarrhea due to rotavirus, their use in the treatment of diarrhea is yet to be recommended, even in developed countries. The children of developing countries might benefit from zinc supplementation during the diarrheal illness, but its mode of delivery and cost effectiveness are yet to be decided.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12608880     DOI: 10.2165/00128072-200305030-00002

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  87 in total

1.  Efficacy and safety of oral rehydration solution with reduced osmolarity in adults with cholera: a randomised double-blind clinical trial. CHOICE study group.

Authors:  N H Alam; R N Majumder; G J Fuchs
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

2.  Effects of indigestible dietary bulk and short chain fatty acids on the tissue weight and epithelial cell proliferation rate of the digestive tract in rats.

Authors:  T Sakata
Journal:  J Nutr Sci Vitaminol (Tokyo)       Date:  1986-08       Impact factor: 2.000

3.  Acetorphan prevents cholera-toxin-induced water and electrolyte secretion in the human jejunum.

Authors:  T A Hinterleitner; W Petritsch; G Dimsity; H Berard; J M Lecomte; G J Krejs
Journal:  Eur J Gastroenterol Hepatol       Date:  1997-09       Impact factor: 2.566

4.  Paralytic ileus, a serious complication in acute diarrhoea disease among infants in developing countries.

Authors:  A Murtaza; S R Khan; K S Butt; Y Finkel; A Aperia
Journal:  Acta Paediatr Scand       Date:  1989-09

5.  Human serum immunoglobulin counteracts rotaviral infection in Caco-2 cells.

Authors:  A Guarino; A Casola; E Bruzzese; M Saini; L Nitsch; A Rubino
Journal:  Pediatr Res       Date:  1996-12       Impact factor: 3.756

6.  Loperamide in acute diarrhoea in childhood: results of a double blind, placebo controlled multicentre clinical trial. Diarrhoeal Diseases Study Group (UK).

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1984-11-10

7.  Utilization of nutrients by isolated epithelial cells of the rat colon.

Authors:  W E Roediger
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

8.  Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea.

Authors:  A Guarino; R B Canani; M I Spagnuolo; F Albano; L Di Benedetto
Journal:  J Pediatr Gastroenterol Nutr       Date:  1997-11       Impact factor: 2.839

Review 9.  Thoracic amebiasis.

Authors:  S M Shamsuzzaman; Y Hashiguchi
Journal:  Clin Chest Med       Date:  2002-06       Impact factor: 2.878

10.  Chlorpromazine reduces fluid-loss in cholera.

Authors:  G H Rabbani; W B Greenough; J Holmgren; I Lönnroth
Journal:  Lancet       Date:  1979-02-24       Impact factor: 79.321

View more
  35 in total

Review 1.  Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

Authors:  Roberto Berni Canani; Margherita Di Costanzo; Ludovica Leone; Monica Pedata; Rosaria Meli; Antonio Calignano
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

2.  Diagnostic limitations to accurate diagnosis of cholera.

Authors:  Munirul Alam; Nur A Hasan; Marzia Sultana; G Balakrish Nair; A Sadique; A S G Faruque; Hubert P Endtz; R B Sack; A Huq; R R Colwell; Hidemasa Izumiya; Masatomo Morita; Haruo Watanabe; Alejandro Cravioto
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

Review 3.  Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention.

Authors:  Firdausi Qadri; Ann-Mari Svennerholm; A S G Faruque; R Bradley Sack
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

Review 4.  Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.

Authors:  Vanessa R Anderson; Monique P Curran
Journal:  Drugs       Date:  2007       Impact factor: 9.546

5.  Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations.

Authors:  Roberto Berni Canani; Pia Cirillo; Gianluca Terrin; Luisa Cesarano; Maria Immacolata Spagnuolo; Anna De Vincenzo; Fabio Albano; Annalisa Passariello; Giulio De Marco; Francesco Manguso; Alfredo Guarino
Journal:  BMJ       Date:  2007-08-09

Review 6.  Zinc: Role in the management of diarrhea and cholera.

Authors:  M Imran Qadir; Arfa Arshad; Bashir Ahmad
Journal:  World J Clin Cases       Date:  2013-07-16       Impact factor: 1.337

7.  Clinical risk factors, bacterial aetiology, and outcome of urinary tract infection in children hospitalized with diarrhoea in Bangladesh.

Authors:  R Das; T Ahmed; H Saha; L Shahrin; F Afroze; A S M S B Shahid; K M Shahunja; P K Bardhan; M J Chisti
Journal:  Epidemiol Infect       Date:  2016-12-28       Impact factor: 4.434

8.  Predictors and outcome of hypoxemia in severely malnourished children under five with pneumonia: a case control design.

Authors:  Mohammod Jobayer Chisti; Mohammed Abdus Salam; Hasan Ashraf; Abu S G Faruque; Pradip Kumar Bardhan; Abu S M S B Shahid; K M Shahunja; Sumon Kumar Das; Tahmeed Ahmed
Journal:  PLoS One       Date:  2013-01-08       Impact factor: 3.240

9.  Clonal transmission, dual peak, and off-season cholera in Bangladesh.

Authors:  Munirul Alam; Atiqul Islam; Nurul A Bhuiyan; Niaz Rahim; Anowar Hossain; G Yeahia Khan; Dilruba Ahmed; Haruo Watanabe; Hidemasa Izumiya; Abu S G Faruque; Ali S Akanda; Shafiqul Islam; R Bradley Sack; Anwar Huq; Rita R Colwell; Alejandro Cravioto
Journal:  Infect Ecol Epidemiol       Date:  2011-08-08

10.  Occult pneumonia: an unusual but perilous entity presenting with severe malnutrition and dehydrating diarrhoea.

Authors:  Mohammod J Chisti; Mohammed A Salam; Mark A C Pietroni
Journal:  J Health Popul Nutr       Date:  2009-12       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.